Calder Biosciences
Calder Biosciences is developing the next-generation of recombinant protein vaccines with its patented 3D-Vaxlock™ technology, driving increased potency and more durable protection against infectious diseases.
Calder Biosciences is developing the next-generation of recombinant protein vaccines with its patented 3D-Vaxlock™ technology, driving increased potency and more durable protection against infectious diseases.